Sleep duration and breast cancer risk in the Breast Cancer Detection Demonstration Project follow-up cohort

British Journal of Cancer

Volumn 112, Issue 3, 2015, Pages 567-571

  Qian, X ^a   Brinton, L A ^a   Schairer, C ^a   Matthews, C E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

breast cancer; hormone receptor negative breast cancer; hormone receptor positive breast cancer; sleep

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP; SLEEP TIME; AGE; BODY MASS; BREAST NEOPLASMS; EARLY DIAGNOSIS; ESTROGEN THERAPY; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TIME;

AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RISK FACTORS; SLEEP; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84922258229     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.600     Document Type: Article

References (18)

1. Blask DE (2009) Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 13(4): 257-264
2. Chen WY, Colditz GA (2007) Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol 4(7): 415-423.
3. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C Sanchez-Barcelo EJ (2006) Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 30(2): 118-128.
4. Flood A, Velie EM, Chaterjee N, Subar AF, Thompson FE, Lacey Jr JV Schairer C, Troisi R, Schatzkin A (2002) Fruit and vegetable intakes and the risk of colorectal cancer in the Breast Cancer Detection Demonstration Project follow-up cohort. Am J Clin Nutr 75(5): 936-943.
5. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F Pickering TG, Rundle AG, Zammit GK, Malaspina D (2007) Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 30(12): 1667-1673.
6. Girschik J, Heyworth J, Fritschi L (2013) Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol 177(4): 316-327.
7. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S (2006) Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166(16): 1756-1762.
8. Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A, Nakaya N Fukudo S, Tsuji I (2008) Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99(9): 1502-1505.
9. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ (2008) Self-reported and measured sleep duration: how similar are they? Epidemiology 19(6): 838-845.
10. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A Hampton JM, Egan KM (2006) Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 15(3): 241-249.
11. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66(10): 5521-5525.
12. Qin Y, Zhou Y, Zhang X, Wei X, He J (2013) Sleep duration and breast cancer risk: A meta-analysis of observational studies. Int J Cancer 134: 1166-1173.
13. Stevens RG (2005) Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16(2): 254-258.
14. Van Cauter E, Knutson KL (2008) Sleep and the epidemic of obesity in children and adults. Eur J Endocrinol 159(Suppl 1): S59-S66.
15. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65(20): 9595-9600.
16. Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y Lewis CE, Manson JE, Chlebowski RT (2013) Association between sleep and breast cancer incidence among postmenopausal women in the womens health initiative. Sleep 36(10): 1437-1444.
17. Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM, Yu MC (2013) Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 132(4): 891-896.
18. Yang WS, Deng Q, Fan WY, Wang WY, Wang X (2014) Light exposure at night, sleep duration, melatonin, and breast cancer: a dose-response analysis of observational studies. Eur J Cancer Prev 23(4): 269-276.